winepressnews.com Last week an Israeli-based startup company has raised $8.25 million in a new round of funding for their mRNA-based vaccines for shrimp populations.
ViAqua Therapeutics is developing a orally administered encapsuled solution that utilizes mRNA tech, the same ingredients used in the Pfizer and Moderna Covid-19 vaccines, that is designed to prevent White Spot Virus (WSSV); a deadly viral infection that plagues shrimp populations, costing an annual loss of around $3 billion and a 15% reduction in global shrimp production.
The company plans to begin production of their new treatment in India by 2024.
Read Full Article Here…(winepressnews.com)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
